Story thread · 2 reports / 2 sources
Atossa Therapeutics GAAP EPS of -$0.95
seekingalpha.com · 4d
First report: Atossa Therapeutics founder to be selected as NIAID director — report — endpts.com, 6d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.